Cargando…
Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials
BACKGROUND: Intravenous glucocorticoids are recommended for multiple sclerosis (MS). However, they can be inconvenient and expensive. Due to their convenience and low cost, oral glucocorticoids may be an alternative treatment. Recently, several studies have shown that there is no difference in effic...
Autores principales: | Liu, Shuo, Liu, Xiaoqiang, Chen, Shuying, Xiao, Yingxiu, Zhuang, Weiduan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703548/ https://www.ncbi.nlm.nih.gov/pubmed/29176905 http://dx.doi.org/10.1371/journal.pone.0188644 |
Ejemplares similares
-
Neutrophil–lymphocyte ratio predicts the outcome of intracerebral hemorrhage: A meta-analysis
por: Liu, Shuo, et al.
Publicado: (2019) -
Prognostic factors associated with survival in patients with anaplastic oligodendroglioma
por: Liu, Shuo, et al.
Publicado: (2019) -
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2022) -
Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis
por: Zhou, Shaojiong, et al.
Publicado: (2020) -
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
por: Caster, Ola, et al.
Publicado: (2015)